All atropine Articles
-
193Latest Myopia NewsEyenovia Terminates Phase 3 CHAPERONE Study
November 15, 2024 NEW YORK, NY — Eyenovia has shared that its Phase 3 CHAPERONE study is currently not meeting its primary...
-
329Research ReviewPutting Myopia Control Efficacy into Context
November 15, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE In the article “Putting efficacy into context: do controlled trials on...
-
72ClinicalChildhood Myopia and Dry Eye: Are They Related?
November 1, 2024 By James S. Wolffsohn BSc, MBA, PhD, Professor and Dean of the School of Optometry, Aston University There is...
-
746Research ReviewThe Impact of Rebound
November 1, 2024 Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE In their review article, “Efficacy in myopia control — The impact of...
-
678Research ReviewFive-Year Results of Atropine 0.01% Efficacy in Myopia Control in a European Population
October 1, 2024 By Diba Rezazadeh, OD, AdvCertChVis(ACO) Topical low-dose atropine has become a popular myopia control treatment, and its ability to...
-
999Research ReviewAdd-On Effect of Using 0.05% Atropine in Fast OrthoK Progressors
October 1, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE The retrospective study conducted by Wen et al. (2024) aimed to...
-
122FinancialConveying the Value of Myopia Management is Key When Presenting Fees
October 1, 2024 By David Anderson, OD, and Taylor Sprague, OD, FAAO One major challenge with presenting myopia management to patients and...
-
663Patient CommunicationEducating Health Care Professionals about Myopia Management Gets More Patients Treatment
September 16, 2024 By Y. Shira Kresch, OD, MS, FAAO We want our patients to be educated about the risks of untreated...
-
611Research ReviewCan We Differentiate Between ‘Responders’ and ‘Non-Responders’ to Myopia Control Interventions?
September 16, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE In their article “Can we really distinguish ‘responders’ from ‘non-responders’ to...
-
433Research ReviewAtropine Monotherapy vs. Combined with MiSight 1 Day Contact Lenses
September 3, 2024 By Rumeysa Doger, BBioMed, OD Topical atropine is among the myopia treatments with proven efficacy, though treatment effect, side...
-
1.6KEditor’s PerspectiveCombination Therapy in Myopia Management
August 1, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE To determine the success of any juvenile-onset myopia intervention, it is...
-
246ClinicalWhich Myopic Children Will Benefit From Low-Dose Atropine?
August 1, 2024 By Catherine Tay, BOptom, GradCertPublicHealth Environmental factors, genetic factors, and patient characteristics are important determinants that may help guide...
-
832Latest Myopia NewsSydnexis Names Perry J. Sternberg CEO
July 16, 2024 DEL MAR, Calif. — Sydnexis has officially named a new Chief Executive Officer and member of the Board of...
-
962Research ReviewSignificant Advances in Myopia Control Strategies for Children
June 17, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE While myopia can be optically corrected, such corrections cannot address the...
-
931Research ReviewEfficacy of 0.01% Atropine Eye Drops for Myopia Control in European Children
June 3, 2024 By Eman Ali Alzghoul, PhD candidate at the School of Optometry and Vision Science, University of New South Wales...
-
518Latest Myopia News
Vyluma Receives EU Marketing Application Authorization for Low-Dose Atropine NVK002
May 29, 2024 BRIDGEWATER, N.J. — Vyluma announced it has received approval from the European Medicines Agency (EMA) of its Marketing Authorization...
-
883PodcastsA Distant Mirror: How Is China Addressing Myopia?
May 6, 2024 While in Shanghai to attend the “Frontier in Vision Science Summit — Myopia Research,” Review of Myopia Management took...
-
1.0KResearch ReviewSeeing Beyond Efficacy
May 1, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE The management of juvenile-onset myopia is a critical public health issue,...
-
859Research ReviewFive-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study
April 15, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Topical low-concentration atropine eye drops to help slow the progression of...
-
413ClinicalLow-dose Atropine and OrthoK: What Does the Evidence Say?
April 1, 2024 By Eman Ali Alzghoul, PhD candidate at the School of Optometry and Vision Science, University of New South Wales...
-
1.3KResearch ReviewCompounded 0.01% Atropine — What’s in the Bottle?
February 1, 2024 By Luke Seesink, BApplSci According to this study, there is significant variability in the quality and consistency of compounded...
-
761Latest Myopia NewsEyenovia Regains Rights to MicroPine Atropine Spray in U.S. and Canada
January 18, 2024 NEW YORK — Eyenovia has regained the rights to MicroPine, an investigational eight microliter ophthalmic spray of atropine delivered by...
-
843Research ReviewPrevention of Myopia Shift and Myopia Onset Using 0.01% Atropine in Pre-Myopic Children
January 15, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE According to the International Myopia Institute (IMI) white paper Defining and...
-
1.8KClinicalAffirming the Importance of Short-Term Trials Complemented with Long-Term Follow-Up
December 15, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Clinical trial results of topical atropine eye drops for childhood myopia...
-
1.4KClinicalObstacles with Compounded Low-Dose Atropine
sponsored content November 1, 2023 By Erin S. Tomiyama, OD, PhD, FAAO Most compounding pharmacies are small and do not have the...
-
1.1KResearch Review
Effect of Topical Low-Dose Atropine on Binocular Vision and Accommodation
August 1, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Eye care professionals frequently prescribe topical low-dose atropine to slow myopic...
-
1.4KResearch ReviewCombination Therapy for Myopia Progression Control
July 5, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Most published myopia clinical trials study a single intervention versus control,...